The changing market conditions have greatly benefited some stocks while others have taken a huge blow. Below, I have chosen five stocks which seem to be the best options to buy right now for me. This is because they are stable and are steadily growing. They also have lower risk involved and offer high returns to investors. Here are my five top picks right now:
I will start off with NiSource (NI, Financial). I believe that the price of this issue will rise further. Earnings per share (EPS) are a little above $1 and the price-to-earnings (P/E) ratio is 23. The stock has a dividend yield of nearly 4% and the last dividend paid out was 23c per share. There are over 281 million outstanding shares in the market. The debt-to-equity ratio is close to 1.60 and the beta for this stock is calculated at 0.75. This means that the stock is a relatively safer investment and the company is stable too. There are positive trends being seen in terms of income growth and the profit margins too have increased.
According to recent news, the stock is trading higher than the 50-day moving average and volumes have been rising steadily during this quarter. The stock has been given a rating of 8 out of 10 by analysts. They suggest that the investors should hold on to this stock because there are chances of future growth and returns. I believe that this would be a viable option to buy because of upside potential which will offer returns and capital gains.
My next pick is NuStar Energy LP (NS, Financial). Earnings per share are nearly $3 and the price-to-earnings (P/E) is 22. Dividend yield for this stock is 7.25% and the last dividend paid to shareholders amounted to $1.10 per share. The beta is calculated to be 0.43 which means that this is a safe investment. Positive trends have been seen in sales growth over the last quarter. Experts have given a rating of 8 out of 10 to this stock and suggest that investors should hold on to it for a while. This stock is also categorized as one of the five best buy options which offer significant yields. With steadily rising income and a well-managed debt and free cash flow, this stock is an attractive option for investors looking to maximize income. In my opinion, this is a good investment option based on the fact that the risk is low and returns are high.
My third choice is Nucor (NUE, Financial). The current trading price of this stock is above $44 per share. It was being predicted that the price will remain unchanged but then it rose by 0.34% since the previous closure. The 52-week trading range is between $29 and $49 per share approximately. Market capitalization at current price is almost $14 billion and the average trading volume is almost 3 million. Earnings per share are more than $2 and the price-to-earnings (P/E) are a little above 18. Dividend yield is close to 3.30% and the last dividend paid by the company was 37c per share. There are nearly 317 million shares outstanding in the market. The debt-to-equity ratio is 0.57 and the beta is calculated to be 1.10. This indicates that the stock is not very risky to invest in and the company is quite stable as well.
There are positive trends in sales and income growth. Experts have given a rating of 7 out of 10 to this stock and suggest that it is a definite buy option. It is being categorized as one of the stocks whichpay high dividends and are steadily growing. In my opinion, it would be a viable option to invest in this stock. This is because it offers higher returns, is not very risky and also has a lot of potential for upside and growth in future.
My next choice is Sanofi ADS (SNY, Financial). The current trading price of this stock is just above $37 per share. The price was predicted to stay constant but it has been increasing steadily. Experts and analysts predict that it might increase further. The 52-week trading range of this stock is between $30 and $45 per share approximately. Market capitalization at current price is almost $100 billion and the average trading volume is more than 3 million. The dividend yield is nearly 5% and the last dividend paid was $1.76 per share. There are almost 3 billion outstanding shares in the market. Earnings per share are close to $3 and the price-to-earnings (P/E) ratio is 19. Debt-to-equity is 0.27 and the beta is calculated at 0.88. Sales and income are growing steadily too and the profit margin is nearly 14%.
Experts have given this stock a rating of 7 out of 10 and suggest that it has a lot of potential for growth. Recent news has highlighted the fact that the market is growing and expanding. Sanofi has a lot of potential for growth and it seems that they are capitalizing on the opportunities at hand. This is why I believe that this stock would be a good investment option.
Lastly, I have chosen Windstream (WIN, Financial). The current trading price of this stock is almost $13 per share. Some experts predict that the price will now stabilize itself and not change for some time. On the other, some experts believe that it will increase further. The 52-week trading range is between $10 and $14 per share approximately. Market capitalization at current price is more than $7 billion and the average trading volume is almost 7 million. Earnings per share are close to $1 and the price-to-earnings (P/E) ratio is a little above 24. Dividend yield is slightly more than 8% and the last dividend paid by the company was 25c per share. There are nearly 516 million shares outstanding in the market. Debt-to-equity ratio is close to 9 and the beta is calculated to be 0.84. This means that the stock is safer than the market average.
Experts and analysts believe that investors should hold on to this stock. Sales are growing steadily and the profit margins are approximately 6%. The company will announce its earnings this month. It is being predicted that there might be a 5.3% increase in dividends since the last quarter. Its financial highlights for this quarter seem to be impressive and there is steady growth. This means that there are opportunities available to investors for growth and income. In my opinion, this stock has upside potential and can offer high returns to its investors with low risk.
I will start off with NiSource (NI, Financial). I believe that the price of this issue will rise further. Earnings per share (EPS) are a little above $1 and the price-to-earnings (P/E) ratio is 23. The stock has a dividend yield of nearly 4% and the last dividend paid out was 23c per share. There are over 281 million outstanding shares in the market. The debt-to-equity ratio is close to 1.60 and the beta for this stock is calculated at 0.75. This means that the stock is a relatively safer investment and the company is stable too. There are positive trends being seen in terms of income growth and the profit margins too have increased.
According to recent news, the stock is trading higher than the 50-day moving average and volumes have been rising steadily during this quarter. The stock has been given a rating of 8 out of 10 by analysts. They suggest that the investors should hold on to this stock because there are chances of future growth and returns. I believe that this would be a viable option to buy because of upside potential which will offer returns and capital gains.
My next pick is NuStar Energy LP (NS, Financial). Earnings per share are nearly $3 and the price-to-earnings (P/E) is 22. Dividend yield for this stock is 7.25% and the last dividend paid to shareholders amounted to $1.10 per share. The beta is calculated to be 0.43 which means that this is a safe investment. Positive trends have been seen in sales growth over the last quarter. Experts have given a rating of 8 out of 10 to this stock and suggest that investors should hold on to it for a while. This stock is also categorized as one of the five best buy options which offer significant yields. With steadily rising income and a well-managed debt and free cash flow, this stock is an attractive option for investors looking to maximize income. In my opinion, this is a good investment option based on the fact that the risk is low and returns are high.
My third choice is Nucor (NUE, Financial). The current trading price of this stock is above $44 per share. It was being predicted that the price will remain unchanged but then it rose by 0.34% since the previous closure. The 52-week trading range is between $29 and $49 per share approximately. Market capitalization at current price is almost $14 billion and the average trading volume is almost 3 million. Earnings per share are more than $2 and the price-to-earnings (P/E) are a little above 18. Dividend yield is close to 3.30% and the last dividend paid by the company was 37c per share. There are nearly 317 million shares outstanding in the market. The debt-to-equity ratio is 0.57 and the beta is calculated to be 1.10. This indicates that the stock is not very risky to invest in and the company is quite stable as well.
There are positive trends in sales and income growth. Experts have given a rating of 7 out of 10 to this stock and suggest that it is a definite buy option. It is being categorized as one of the stocks whichpay high dividends and are steadily growing. In my opinion, it would be a viable option to invest in this stock. This is because it offers higher returns, is not very risky and also has a lot of potential for upside and growth in future.
My next choice is Sanofi ADS (SNY, Financial). The current trading price of this stock is just above $37 per share. The price was predicted to stay constant but it has been increasing steadily. Experts and analysts predict that it might increase further. The 52-week trading range of this stock is between $30 and $45 per share approximately. Market capitalization at current price is almost $100 billion and the average trading volume is more than 3 million. The dividend yield is nearly 5% and the last dividend paid was $1.76 per share. There are almost 3 billion outstanding shares in the market. Earnings per share are close to $3 and the price-to-earnings (P/E) ratio is 19. Debt-to-equity is 0.27 and the beta is calculated at 0.88. Sales and income are growing steadily too and the profit margin is nearly 14%.
Experts have given this stock a rating of 7 out of 10 and suggest that it has a lot of potential for growth. Recent news has highlighted the fact that the market is growing and expanding. Sanofi has a lot of potential for growth and it seems that they are capitalizing on the opportunities at hand. This is why I believe that this stock would be a good investment option.
Lastly, I have chosen Windstream (WIN, Financial). The current trading price of this stock is almost $13 per share. Some experts predict that the price will now stabilize itself and not change for some time. On the other, some experts believe that it will increase further. The 52-week trading range is between $10 and $14 per share approximately. Market capitalization at current price is more than $7 billion and the average trading volume is almost 7 million. Earnings per share are close to $1 and the price-to-earnings (P/E) ratio is a little above 24. Dividend yield is slightly more than 8% and the last dividend paid by the company was 25c per share. There are nearly 516 million shares outstanding in the market. Debt-to-equity ratio is close to 9 and the beta is calculated to be 0.84. This means that the stock is safer than the market average.
Experts and analysts believe that investors should hold on to this stock. Sales are growing steadily and the profit margins are approximately 6%. The company will announce its earnings this month. It is being predicted that there might be a 5.3% increase in dividends since the last quarter. Its financial highlights for this quarter seem to be impressive and there is steady growth. This means that there are opportunities available to investors for growth and income. In my opinion, this stock has upside potential and can offer high returns to its investors with low risk.
